Genetic company holds patents for some specific genes was sued

The American Civil Liberties Union has sued a genetics company that holds patents on breast- and ovarian-cancer-causing genes, saying their claims on the two genes hinders further research by other companies and scientists, the Associated Press/CBS News reports. ACLU lawyers have argued the discovery of the genes should not be rewarded with a patent because each is an “ancient secret of nature.” A defense lawyer for Myriad Genetics, the company, argued all discoveries are routed in nature and warned that a ruling against the firm would endanger the entire biotech sector (2/2).
The Myriad lawyer “dismissed the litigation as a test case to ‘go after gene patents and the biotech industry as a whole’ and said patents have a positive impact on human health because they promote innovation,” Reuters reports. “The lawsuit by the ACLU, the Association for Molecular Pathology, individual women and others was brought against the U.S. Patent and Trademark Office, Myriad Genetics and the University of Utah Research Foundation, which hold the patents on the … genes” (Honan, 2/2).


Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

Scientists looking for new generation treatment of breast cancer

Many women live with breast cancer that does not respond to standard medical treatment, a condition that researchers at the Virginia G. Piper Cancer Center at Scottsdale Healthcare want to

3 Ways to Reduce Your Risk of Skin Cancer

The sun may provide necessary light and energy here on Earth, but it can also pose some dangers. Approximately 4.3 million Americans are diagnosed with basal cell carcinoma (the most

Maybe there is cure for dementia – re-growth of the brain cells show Canadian scientist

A team of scientists from the University of Lethbridge’s Canadian Centre for Behavioural Neuroscience (CCNB) has confirmed the first ever successful example of brain cell re-growth in an adult rat.